Most of the osteoclastogenic factors present in RA joints are thought to act indirectly, enhancing RANKL expression and thereby altering the RANK/RANKL/OPG system, which is the final regulator of bone resorption [2,3,49]. The gene discussed is TNFSF11; the disease is rheumatoid arthritis.